This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, M.-T. M.
Right arrow Articles by Cullen, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, M.-T. M.
Right arrow Articles by Cullen, B. R.

 Previous Article  |  Next Article 

Journal of Virology, November 2003, p. 11964-11972, Vol. 77, No. 22
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.22.11964-11972.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary Macrophages by Using Tat- or CCR5-Specific Small Interfering RNAs Expressed from a Lentivirus Vector

Ming-Ta M. Lee,1 Glen A. Coburn,1 Myra O. McClure,2 and Bryan R. Cullen1*

Howard Hughes Medical Institute and Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina 27710,1 Jefferiss Research Trust Laboratories, Wright-Fleming Institute, Imperial College School of Medicine at St. Mary's, London W2 1PG, United Kingdom2

Received 27 May 2003/ Accepted 28 July 2003

Although several groups have demonstrated that RNA interference, induced by transfection of small interfering RNA (siRNA) duplexes, can protect cells against a viral challenge in culture, this protection is transient. Here, we describe lentivirus expression vectors that can stably express siRNAs at levels sufficient to block virus replication. We have used these vectors to stably express siRNAs specific for the essential human immunodeficiency virus type 1 (HIV-1) Tat transcription factor or specific for a cellular coreceptor, CCR5, that is required for infection by the majority of primary HIV-1 isolates. These lentivirus vectors are shown to protect cells, including primary macrophages, against HIV-1 infection in culture by inducing selective degradation of their target mRNA species. These data suggest that it should be possible to block the expression of specific viral or cellular genes in vivo by using viral vectors to stably express the appropriate siRNAs.


* Corresponding author. Mailing address: Box 3025, Duke University Medical Center, Durham, NC 27710. Phone: (919) 684-3369. Fax: (919) 681-8979. E-mail: culle002{at}mc.duke.edu.


Journal of Virology, November 2003, p. 11964-11972, Vol. 77, No. 22
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.22.11964-11972.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Subramanian, M., Pilli, T., Bhattacharya, P., Pacini, F., Nikiforov, Y. E., Kanteti, P. V., Prabhakar, B. S. (2009). Knockdown of IG20 Gene Expression Renders Thyroid Cancer Cells Susceptible to Apoptosis. J. Clin. Endocrinol. Metab. 94: 1467-1471 [Abstract] [Full Text]  
  • Li, L. C., Sheng, J. R., Mulherkar, N., Prabhakar, B. S., Meriggioli, M. N. (2008). Regulation of Apoptosis and Caspase-8 Expression in Neuroblastoma Cells by Isoforms of the IG20 Gene. Cancer Res. 68: 7352-7361 [Abstract] [Full Text]  
  • Lin, J., Cullen, B. R. (2007). Analysis of the Interaction of Primate Retroviruses with the Human RNA Interference Machinery. J. Virol. 81: 12218-12226 [Abstract] [Full Text]  
  • Westerhout, E. M., Berkhout, B. (2007). A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res 35: 4322-4330 [Abstract] [Full Text]  
  • Mulherkar, N., Prasad, K. V., Prabhakar, B. S. (2007). MADD/DENN Splice Variant of the IG20 Gene Is a Negative Regulator of Caspase-8 Activation: KNOCKDOWN ENHANCES TRAIL-INDUCED APOPTOSIS OF CANCER CELLS. J. Biol. Chem. 282: 11715-11721 [Abstract] [Full Text]  
  • Cai, X., Cullen, B. R. (2007). The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 13: 313-316 [Abstract] [Full Text]  
  • Yamamoto, T., Miyoshi, H., Yamamoto, N., Yamamoto, N., Inoue, J.-i., Tsunetsugu-Yokota, Y. (2006). Lentivirus vectors expressing short hairpin RNAs against the U3-overlapping region of HIV nef inhibit HIV replication and infectivity in primary macrophages. Blood 108: 3305-3312 [Abstract] [Full Text]  
  • Merrill, M. K., Gromeier, M. (2006). The Double-Stranded RNA Binding Protein 76:NF45 Heterodimer Inhibits Translation Initiation at the Rhinovirus Type 2 Internal Ribosome Entry Site. J. Virol. 80: 6936-6942 [Abstract] [Full Text]  
  • Gottwein, E., Cai, X., Cullen, B. R. (2006). A Novel Assay for Viral MicroRNA Function Identifies a Single Nucleotide Polymorphism That Affects Drosha Processing.. J. Virol. 80: 5321-5326 [Abstract] [Full Text]  
  • Reuter, T., Weissbrich, B., Schneider-Schaulies, S., Schneider-Schaulies, J. (2006). RNA Interference with Measles Virus N, P, and L mRNAs Efficiently Prevents and with Matrix Protein mRNA Enhances Viral Transcription.. J. Virol. 80: 5951-5957 [Abstract] [Full Text]  
  • Waldele, K., Silbermann, K., Schneider, G., Ruckes, T., Cullen, B. R., Grassmann, R. (2006). Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood 107: 4491-4499 [Abstract] [Full Text]  
  • Merrill, M. K., Dobrikova, E. Y., Gromeier, M. (2006). Cell-Type-Specific Repression of Internal Ribosome Entry Site Activity by Double-Stranded RNA-Binding Protein 76.. J. Virol. 80: 3147-3156 [Abstract] [Full Text]  
  • Lee, S.-K., Dykxhoorn, D. M., Kumar, P., Ranjbar, S., Song, E., Maliszewski, L. E., Francois-Bongarcon, V., Goldfeld, A., Swamy, N. M., Lieberman, J., Shankar, P. (2005). Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 106: 818-826 [Abstract] [Full Text]  
  • Kim, Y.-S., Kim, J.-M., Jung, D.-L., Kang, J.-E., Lee, S., Kim, J. S., Seol, W., Shin, H.-C., Kwon, H. S., Van Lint, C., Hernandez, N., Hur, M.-W. (2005). Artificial Zinc Finger Fusions Targeting Sp1-binding Sites and the trans-Activator-responsive Element Potently Repress Transcription and Replication of HIV-1. J. Biol. Chem. 280: 21545-21552 [Abstract] [Full Text]  
  • Yuan, J., Cheung, P. K. M., Zhang, H. M., Chau, D., Yang, D. (2005). Inhibition of Coxsackievirus B3 Replication by Small Interfering RNAs Requires Perfect Sequence Match in the Central Region of the Viral Positive Strand. J. Virol. 79: 2151-2159 [Abstract] [Full Text]  
  • YI, R., DOEHLE, B. P., QIN, Y., MACARA, I. G., CULLEN, B. R. (2005). Overexpression of Exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA 11: 220-226 [Abstract] [Full Text]  
  • Dave, R. S., Pomerantz, R. J. (2004). Antiviral Effects of Human Immunodeficiency Virus Type 1-Specific Small Interfering RNAs against Targets Conserved in Select Neurotropic Viral Strains. J. Virol. 78: 13687-13696 [Abstract] [Full Text]  
  • Le, Y., Iribarren, P., Zhou, Y., Gong, W., Hu, J., Zhang, X., Wang, J. M. (2004). Silencing the Formylpeptide Receptor FPR by Short-Interfering RNA. Mol. Pharmacol. 66: 1022-1028 [Abstract] [Full Text]  
  • Ge, Q., Filip, L., Bai, A., Nguyen, T., Eisen, H. N., Chen, J. (2004). Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA 101: 8676-8681 [Abstract] [Full Text]  
  • Tompkins, S. M., Lo, C.-Y., Tumpey, T. M., Epstein, S. L. (2004). Protection against lethal influenza virus challenge by RNA interference in vivo. Proc. Natl. Acad. Sci. USA 101: 8682-8686 [Abstract] [Full Text]  
  • Segal, D. J., Goncalves, J., Eberhardy, S., Swan, C. H., Torbett, B. E., Li, X., Barbas, C. F. III (2004). Attenuation of HIV-1 Replication in Primary Human Cells with a Designed Zinc Finger Transcription Factor. J. Biol. Chem. 279: 14509-14519 [Abstract] [Full Text]